CIBC World Market’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
11,478
-7,042
| -38% | -$66.1K | ﹤0.01% | 1237 |
|
|
2025
Q1 | $132K | Sell |
18,520
-1,543
| -8% | -$11K | ﹤0.01% | 1211 |
|
|
2024
Q4 | $234K | Buy |
20,063
+3,657
| +22% | +$42.7K | ﹤0.01% | 1168 |
|
|
2024
Q3 | $337K | Sell |
16,406
-1,695
| -9% | -$34.8K | ﹤0.01% | 1022 |
|
|
2024
Q2 | $405K | Sell |
18,101
-2,136
| -11% | -$47.8K | ﹤0.01% | 946 |
|
|
2024
Q1 | $557K | Buy |
20,237
+359
| +2% | +$9.88K | ﹤0.01% | 884 |
|
|
2023
Q4 | $606K | Buy |
19,878
+4,479
| +29% | +$137K | ﹤0.01% | 812 |
|
|
2023
Q3 | $487K | Buy |
15,399
+876
| +6% | +$27.7K | ﹤0.01% | 825 |
|
|
2023
Q2 | $592K | Buy |
14,523
+6,791
| +88% | +$277K | ﹤0.01% | 806 |
|
|
2023
Q1 | $288K | Sell |
7,732
-765
| -9% | -$28.5K | ﹤0.01% | 986 |
|
|
2022
Q4 | $296K | Buy |
8,497
+453
| +6% | +$15.8K | ﹤0.01% | 962 |
|
|
2022
Q3 | $450K | Sell |
8,044
-990
| -11% | -$55.4K | ﹤0.01% | 827 |
|
|
2022
Q2 | $468K | Buy |
9,034
+4,294
| +91% | +$222K | ﹤0.01% | 823 |
|
|
2022
Q1 | $344K | Buy |
4,740
+1,522
| +47% | +$110K | ﹤0.01% | 1003 |
|
|
2021
Q4 | $380K | Buy |
3,218
+752
| +30% | +$88.8K | ﹤0.01% | 982 |
|
|
2021
Q3 | $331K | Sell |
2,466
-696
| -22% | -$93.4K | ﹤0.01% | 1044 |
|
|
2021
Q2 | $512K | Sell |
3,162
-2,098
| -40% | -$340K | ﹤0.01% | 924 |
|
|
2021
Q1 | $422K | Buy |
+5,260
| New | +$422K | ﹤0.01% | 939 |
|